Huang Li-Rong, Zhong Yong-Jin, Zhang Xiao-Qing, Feng Ze-Ru, Lai Yan-Cheng, Wu Hong-Kun, Mo An-Chun
State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Geriatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Implant Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
BMC Oral Health. 2025 Jan 25;25(1):137. doi: 10.1186/s12903-025-05443-2.
This study aimed to evaluate the osteogenic performance of allograft particulate bone and cortical bone blocks combined with xenograft under bovine pericardium membranes, for treating different degrees of labial bone defects in the aesthetic zone.
Twenty-four patients with bone defects were divided into two groups based on defect severity (Terheyden 1/4 and 2/4 groups). The Terheyden 1/4 group received granular bone grafts alone, while the Terheyden 2/4 group received cortical bone blocks combined with granular bone grafts. Cone beam computed tomography scans were taken preoperatively, immediately postoperatively, and six months postoperatively. Primary outcomes included labial bone formation, alveolar bone formation, bone resorption rate, osteogenic efficiency, and complications.
Labial bone thickness in both groups exceeded 2 mm after six months. Labial bone formation at the implant shoulder in the Terheyden 1/4 group was 2.35 ± 2.68 mm, and 2.26 ± 1.66 mm in the Terheyden 2/4 group (p > 0.05). Labila and alveolar bone formation at 2-5 mm below the implant shoulder was significantly greater in the Terheyden 2/4 group (p < 0.05). Alveolar bone resorption and the bone resorption rate at 2-5 mm below the implant shoulder was lower in the Terheyden 2/4 group (p < 0.05). Osteogenic efficiency was 64.43 ± 2.76%, with no significant difference between groups (p > 0.05). No complications were observed.
Both treatment approaches achieved satisfactory bone regeneration, but combining cortical bone blocks with granular grafts provided better outcomes for larger defects, with greater bone formation and less resorption. Further research with longer follow-up is required to confirm long-term stability.
The study was retrospectively registered in the Chinese Clinical Trial Registry ( http://www.chictr.org.cn/ ) with the registration number ChiCTR2300070538 on April 14, 2023.
本研究旨在评估同种异体颗粒骨和皮质骨块与异种移植物联合置于牛心包膜下,用于治疗美学区不同程度唇侧骨缺损的成骨性能。
24例骨缺损患者根据缺损严重程度分为两组(特尔海德1/4组和2/4组)。特尔海德1/4组仅接受颗粒状骨移植,而特尔海德2/4组接受皮质骨块联合颗粒状骨移植。术前、术后即刻及术后6个月进行锥形束计算机断层扫描。主要观察指标包括唇侧骨形成、牙槽骨形成、骨吸收速率、成骨效率及并发症。
6个月后两组唇侧骨厚度均超过2mm。特尔海德1/4组种植体肩部唇侧骨形成量为2.35±2.68mm,特尔海德2/4组为2.26±1.66mm(p>0.05)。特尔海德2/4组种植体肩部下方2 - 5mm处的唇侧和牙槽骨形成量显著更高(p<0.05)。特尔海德2/4组种植体肩部下方2 - 5mm处的牙槽骨吸收及骨吸收速率更低(p<0.05)。成骨效率为64.43±2.76%,组间差异无统计学意义(p>0.05)。未观察到并发症。
两种治疗方法均实现了满意的骨再生,但皮质骨块与颗粒状移植物联合应用对较大缺损效果更佳,骨形成更多且吸收更少。需要进一步进行更长时间随访的研究以确认长期稳定性。
本研究于2023年4月14日在中国临床试验注册中心(http://www.chictr.org.cn/)进行回顾性注册,注册号为ChiCTR2300070538。